Comment
Author: Admin | 2025-04-28
46°F). Do not freeze.Store in the original carton to protect it from light until the time of reconstitution.Do not shake the reconstituted or diluted solution.IngredientsActive Ingredient: fam-trastuzumab deruxtecan-nxki.Enhertu Inactive Ingredients: L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, and sucrose.CompanyEnhertu is manufactured by: Daiichi Sankyo, Inc., Basking Ridge, NJ 07920 U.S. License No. 2128.Enhertu is marketed by: Daiichi Sankyo, Inc., Basking Ridge, NJ 07920 and AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850.Fam-trastuzumab deruxtecan BiosimilarsBiosimilar and interchangeable products are biological products that are highly similar to and have no clinically meaningful differences from the reference product. Reference products These are biological products that have already been approved by the FDA, against which biosimilar products are compared. There is 1 for fam-trastuzumab deruxtecan. Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, Inc Formulation type Strength Single-Dose Vial 100 mg View Enhertu information in detail. Popular FAQWhat is the success rate of Enhertu in metastatic breast cancer? In the DESTINY-Breast03 study in people with HER2-positive metastatic breast cancer, treatment with Enhertu lengthened the amount of time people lived without their cancer getting worse (called progression free survival) by 72% when compared to another HER2 inhibitor treatment called Kadcyla.In the DESTINY-Breast06 study in people with HER2-low or HER2-ultralow metastatic breast cancer who had not received prior chemotherapy, treatment with Enhertu lengthened median progression free survival (PFS) by 13.2 months compared to 8.1 months in those receiving their doctor's choice of chemotherapy treatment. This was equal to a 36% lower risk of disease progression or death. Continue readingIs Enhertu a chemotherapy drug? What's Enhertu used for? Enhertu (Fam-trastuzumab deruxtecan-nxki) is a chemo drug (chemotherapy) and it is also a targeted therapy anti-cancer drug. Continue readingFurther informationAlways consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.Medical Disclaimer
Add Comment